Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration in astrocytes (Lehre et al., 1995) and GLT-1 proteins have Pietro Peghini, Julia Janzen and been detected only in glial cells of brain (Danbolt et al., Wilhelm Stoffel 1 1992; Pines et al., 1992; Rothstein et al., 1994) . Laboratory of Molecular Neuroscience, Institute of Biochemistry, expression has been shown in cerebellum and placenta by expressed at low levels in brain stem, cortex and hippocampus (Fairman et al., 1995). EAAC-1 is expressed in Four L-glutamate neurotransmitter transporters, the neurons such as pyramidal cells of the CA2-CA4 regions three Na ϩ -dependent GLAST-1, GLT-1 and EAAC-1, of the hippocampus, the dentate gyrus, the granular layer and the Cl --dependent EAAT-4, form a new family of of cerebellum and the cerebral cortical layers II-IV (Kanai structurally related integral plasma membrane and Hediger, 1992; Rothstein et al., 1994) , but also proteins with different distribution in the central nervstrongly in peripheral tissues including kidney, intestine, ous system. They may have pivotal functions in the heart and muscle (Kanai and Hediger, 1992; Mukainaka regulation of synaptic L-glutamate concentration dur et al., 1995). ing neurotransmission and are believed to prevent
Introduction
Neurons are destroyed by sustained exposure to high levels of glutamate (Lucas and Newhouse, 1957; Olney Excitatory synapses are surrounded by powerful, highand Sharpe, 1969; Olney et al., 1971) . Several recent affinity Na ϩ -dependent transporters for the neuroreports suggested a dysfunction of the glutamate uptake transmitter L-glutamate. These transporters terminate the system in some neurodegenerative disorders. A decreased action of this excitatory neurotransmitter in the central capacity for the high-affinity Na ϩ -dependent glutamate nervous system (CNS) by reducing the high L-glutamate uptake is believed to raise the synaptic glutamate concenconcentration in the excitatory synapse after neurotration to excitotoxic levels, causing neuronal death. transmission to that of the resting synapse. Four members Whether the altered glutamate transport is a primary or of a new class of neurotransmitter membrane transporters secondary cause of neurodegeneration, e.g. in special have been discovered: GLAST-1 (Storck et al., 1992) , forms of amyotrophic lateral sclerosis (Plaitakis and GLT-1 (Pines et al., 1992) , EAAC-1 (Kanai and Hediger, Caroscio, 1987; Rothstein et al., 1992; Bensimon et al., 1992) and EAAT-4 (Fairman et al., 1995) . 1994), Huntington's disease (Olney and De Gubareff, The four transporters are glycoproteins with core pro-1978; Perry and Hansen, 1990 ) and Alzheimer's disease teins of 541, 521, 573 and 564 amino acid residues, with (Choi, 1988; Plaitakis et al., 1988; Pomara et al., 1992) , sequence identities between 50 and 55%. They have in is an open question. common a very similar hydrophobicity pattern, but differ
To study the individual role of the three well-charactermost strikingly in their tissue distribution. The glial ized members of the new family of Na ϩ -dependent, hightransporter GLAST-1 was localized by in situ hybridization affinity membrane transporters in vivo, we have chosen and immunochemistry in the oligodendrocyte-related the loss of structure and function approach. Bergmann glia cells surrounding the Purkinje cell layer,
We report here the generation and characterization of a the hippocampus and throughout the cortex (Storck et al., 1992; Rothstein et al., 1994) . GLT-1 mRNAs were found mutant mouse line deficient in the neuronal EAAC-1 Positions of PCR primers are indicated by small arrows. The 5Ј sense oligonucleotide primer (5Ј-CCGCCACGCAAAACCACCGTGCTCGGTCCC-3Ј) is located 150 bp upstream from ATG of exon 1 and the 3Ј antisense primer (5Ј-CTAGTACCACGGCGGCCACGGTTGAGAGCA-3Ј) at the 3Ј end of exon 1. The expected PCR fragments are 250 bp for the wild-type and 1.2 kb for the targeted allele. HSV-TK, thymidine kinase gene derived from herpes simplex virus linked to the phosphoglycerate kinase (PGK) promoter; neo, neomycin transferase gene linked to the PGK promoter. Restriction sites: B, BamHI; E, EcoRI; N, NarI; S, SstI; Sa, SalI; X, XbaI. (B) Southern blot analysis of genomic DNA extracted from ES cells and mouse tails. The DNA was digested with BamHI and EcoRI, and hybridized with the probe. The sizes of wild-type (11.0 kb) and targeted (9.0 kb) alleles are indicated on the right, the genotypes of ES cells and mice below the lanes. (C) PCR analysis of tail genomic DNA extracted from mouse tails. Wild-type (250 bp) and mutant (1.2 kb) fragments were amplified using the set of primers described in (A). The genotypes of mice are indicated below the lanes. (D) Northern blot analysis of 40 μg of total RNA isolated from wild-type, hetero-and homozygous EAAC-1 mutants hybridized with a probe of rat EAAC-1 cDNA. Homozygous EAAC-1 mutants lack the 4.3 and 2.7 kb EAAC-1 mRNAs. GAPDH mRNA signals were used as an internal standard.
transporter. The wild-type transporter EAAC-1 gene was for negative selection ( Figure 1A ). The resulting replacement vector (pEAAC-1.KO) was linearized with ClaI disrupted by homologous recombination with a mutant targeting construct.
and introduced into R1 embryonic stem (ES) cells by electroporation. Transfected ES cells were subjected to negative/positive selection with G418 and gancyclovir.
Results
Resistant ES cell clones carrying the targeted allele were identified by Southern blot analysis of genomic DNA Isolation and partial characterization of the mouse EAAC-1 gene ( Figure 1B ). Positive ES cells were injected into C57BL/6 or CD1 blastocysts. Highly chimeric male animals were Three mouse genomic EAAC-1 clones (M1-3) were isolated from a mouse genomic leukocyte library using a generated that transmitted the mutant allele to their offspring. eaac-1 ϩ/-mice were indistinguishable from wildfull-length EAAC-1 cDNA clone from a λgt10 rat brain cDNA library (W.Stoffel, unpublished data) and derived type animals. They were inbred and eaac-1 -/-offspring were born at the predicted Mendelian ratio. The genotype cDNA fragments. Eight exons and their flanking intron regions were sequenced. Exon sequences correspond to a of mice was determined by Southern blotting of mouse tail DNA restricted with EcoRI/BamHI ( Figure 1B ) and previously published cDNA sequence of murine EAAC-1 (Mukainaka et al., 1995) . The partial gene structure of PCR analysis ( Figure 1C ). The positions of the two oligonucleotide primers are marked in Figure 1A . They mouse EAAC-1 as far as relevant for the present study is shown in Figure 1A .
yielded a 250 bp PCR fragment with the wild-type DNA and a 1.2 kb fragment with the mutant template in which exon 1 is disrupted by the neo cassette. Two mouse lines
Targeted disruption of the mouse EAAC-1 gene For gene targeting, the 7 kb XbaI fragment containing were generated from different ES cell clones, one on the C57BL/6 (eaac-1 -/-.1) and one on the CD1 (eaac-1 -/-.2) exon 1 flanked by 4 kb of genomic DNA on the 5Ј and by 3 kb on the 3Ј side was isolated and subcloned into background. RNA from brain, kidney, small intestine and lung (Kanai pBluescript SKIIϩ. Insertion of a pgk neomycin resistance gene cassette (neo) into the NarI site disrupted exon 1 and Hediger, 1992; Mukainaka et al., 1995) from eaac-1 ϩ/ϩ , eaac-1 ϩ/-and eaac-1 -/-mice was analyzed by and served as a positive selection marker. The thymidine kinase gene was inserted 5Ј of the genomic XbaI fragment Northern blot hybridization ( Figure 1D ). Consistent with a previous report (Mukainaka et al., 1995) , two transcripts 15%). An upregulation of GLAST-1 could clearly be excluded as its signal was equal in wild-type and eaacof different size (4.3 and 2.7 kb) were identified in brain, kidney, small intestine and lung of wild-type and 1 -/-mice. The values obtained for GLT-1 mRNA showed a large variation due to an incomplete transfer of this very heterozygous mice. Neither normal nor truncated mRNA could be detected in the tissues of eaac-1 -/-mice. large size mRNA (12 kb) from the gel to the nylon membrane. Expression of EAAC-1 was detected by in situ hybridization of various brain regions (hippocampus, cerebellum
We therefore applied reverse transcriptase (RT)-PCR with oligonucleotide primers for GLAST-1, GLT-1 and and frontal cortex) in wild-type but not in eaac-1 -/-mice ( Figure 2) . EAAC-1, and for GAPDH as unrelated template, to compare the concentrations of the individual glutamate We conclude that we have generated eaac-1 null mice.
transporter mRNAs (Gilliland et al., 1990) . Amplification was carried out for an increasing number of cycles using
Phenotypic characterization the oligonucleotide primers of the three transporters listed Mice homozygous for the disrupted eaac-1 -/-allele in Materials and methods and of GAPDH as control developed normally. They were viable and fertile with template ( Figure 3 ). normal mating efficiency. They have so far reached an
The resulting PCR bands were quantified correlated to age of Ͼ12 months with no apparent neurological disorder.
the internal GAPDH-control signal by the Image Quant Brain, small intestine and kidneys are tissues with the program. No indication of an enhanced expression of highest eaac-1 expression. We therefore examined the GLAST-1 or GLT-1 in eaac-1 -/-mice was observed histology of these organs from wild-type and eaac-1 -/-in three repetitive experiments within the accuracy of mice. Organ size and morphology at the cellular level the method. were completely normal, and no differences were detected. Most importantly, hippocampus, cerebellum and cortex, eaac-1 -/-mice show no upregulation of GLAST-1 and regions of known high expression of eaac-1, showed an GLT-1. The peptide QYKTKREEVKPVGDP, correspondinconspicuous morphology and normal number of neurons ing to amino acid residues 161-175 of murine EAAC-1 (Figure 2) . (Mukainaka et al., 1995) , coupled to keyhole limpet hemocyanin (KLH) (Goodfriend et al., 1964) was used as eaac-1 -/-mice develop dicarboxylic aminoaciduria.
antigen for the immunization of rabbits. Antibodies were EAAC-1 is not brain specific, but is expressed very affinity purified on a Sepharose column derivatized costrongly in kidney and small intestine ( Figure 1D ). The valently with the peptide listed above. The antibody titer function of EAAC-1 in tubular reabsorption of amino was determined by ELISA (Engvall, 1980) using peptide acids from the glomerular filtrate was studied by analyzing coupled to bovine serum albumin (Reichlin, 1980) . the amino acid pattern and concentrations of plasma and Plasma membranes of brain of wild-type and mutant urine collected in metabolic cages from wild-type and mice were isolated and proteins separated by PAGE (10% EAAC-1-deficient mice over a period of 24 h. Quantitation SDS). Western blot analysis was performed according to of the amino acids present in the deproteinized urine by standard procedures (Sambrook et al., 1989) . automated amino acid analysis revealed an increased Figure 4 represents the Western blot analysis of wildexcretion, 1400-fold for glutamate (240 nmol/g/24 h) and type and eaac-1 -/-plasma membrane-enriched fractions 10-fold for aspartate (5.6 nmol/g/24 h), in EAAC-1-of total brain. Equal amounts of protein were separated deficient compared with wild-type mice ( Figure 3 ). All by 10% SDS-PAGE, proteins transferred by semi-dry other amino acids were present in comparable amounts, blotting, and anti-GLAST-1 and -GLT-1 antibodies applied as were glutamate and aspartate in plasma of the two for the detection and estimation of GLAST-1 (70 kDa) genotypes (eaac-1 ϩ/ϩ : glutamate 25 μM, aspartate 15 μM;
and GLT-1 (73 kDa) proteins in wild-type and eaac-1 -/-eaac-1 -/-: glutamate 36 μM, aspartate 11 μM). These brains of the two phenotypes. The apparent equal intensity findings suggest that EAAC-1 specifically reabsorbs gluof the GLAST-1 and GLT-1 band (Figure 4 ) clearly tamate and aspartate in renal tubuli, and that other renal demonstrates that no overexpression of the two glial amino acid transporters do not compensate for the loss of transporter genes has occurred. its function in the EAAC-1-deficient mouse.
Mice lacking EAAC-1 show neither apoptosis nor reactive EAAC-1 deficiency does not induce upregulation of astroglia. Cryosections of brains of wild-type and eaac-GLAST-1 and GLT-1. Northern and Western blot analyses 1 -/-mice were subjected to the TUNEL (TdT-mediated revealed the low abundance of EAAC-1 in brain compared dUTP nick end labeling) reaction to verify cell apoptosis. with the strong expression of the glial transporters Anti-glial acidic fibrillary protein (GAFP) antibodies were GLAST-1 and GLT-1 (Rothstein et al., 1994) . Since the used to visualize potential astroglial reactivity. No differdeficiency of the neuronal EAAC-1 in the eaac-1 -/-mouse ences between wild-type and mutant mice were observed might upregulate the expression of the glial transporters, (data not shown). we monitored GLAST-1 and/or GLT-1 expression at the mRNA level by Northern blot hybridization analysis of total brain RNA. The signals in three repetitive experi-
Neurological and behavioural assessment
Mice lacking EAAC-1 have normal motor coordination. ments with different homozygous mice were quantified using a PhosphorImager (Molecular Dynamics) using the Motor coordination of wild-type and EAAC-1-deficient mice was challenged in the rotating rod test. The time glyceraldehyde phosphate dehydrogenase (GAPDH) signal as internal standard (median value 98% GLAST-1 mRNA during which the mice were able to stay on a rod rotating at increasing speed (0.8, 1.6, 4, 8, 16 r.p.m.) was compared in eaac-1 -/-compared with wild type, maximal difference convulsant agent (Orloff et al., 1949) , revealed that the bottom, wild-type eaac-1 ϩ/ϩ . EAAC-1-deficient mice show a large peak for glutamate as well as a smaller one for aspartate. All other susceptibility of eaac-1 -/-mice to seizures was comparable amino acids were below the sensitivity of the method, except for to the threshold of wild-type mice. A single i.p. injection glycine, which was also present in the urine of wild-type mice in of 75 mg/kg of PTZ produced the following sequence of considerable amounts. The inset shows the urinary excretion of events: after a latency period, the animals showed single glutamate and aspartate per 24 h in relation to body weight on a whole-body twitches, followed by generalized clonic the whole sequence of events and recovery from every stage was possible, except for the tonic phase, which for male eaac-1 -/-mice from both lines, as well as for invariably led to death. wild-type males of both strains (CD1 and C57BL/6).
Mice from the eaac1 -/-.2 line (n ϭ 10) were compared Motor coordination of eaac-1 -/-and wild-type mice was with wild-type animals derived from matings of heteroindistinguishable. The differences between different wildzygotes (n ϭ 18). The fractions of animals that reached type strains were much larger than those between EAAC-1-different stages in the course of the epileptic reaction to deficient mice and their respective controls ( Figure 6A ).
PTZ are depicted in Figure 7A as a percent of the whole group. More animals of the eaac1 -/-group died, but less Lack of EAAC-1 decreases spontaneous locomotor activity.
reached the stage of convulsive seizures. The differences The spontaneous locomotor activity of the wild-type and were statistically insignificant. mutant mice at p35 was monitored in an open field
The average time that elapsed until different stages of chamber. The total number of squares crossed by male the epileptic response to PTZ occurred is shown in Figure  eaac -1 -/-and wild-type mice during the observation on 3 7B. Animals that proceeded to later stages are included consecutive days is depicted in Figure 6B . eaac-1 -/-mice in the evaluation of the earlier stages. The time course developed about half the locomotor activity of wildwas rather delayed in eaac1 -/-animals, but the differences type mice. This was not due to any overt neurological were statistically not significant (P Ͼ 0.05 in Student's impairment such as pareses of fore-or hindlimbs or signs t-test). of ataxia. Homozygous mutants, however, discontinued their locomotion more frequently and for longer periods of time.
Discussion
Four glutamate transporters are believed to play an importSpatial orientation in Morris water maze in EAAC-1-deficient mice is unimpaired. The Morris water maze task ant role in neurotransmission at excitatory glutamatergic synapses. The individual contribution of the neuronal challenges locomotion, learning and memory of mice (Van der Staay et al., 1992) . Mice were challenged to find a EAAC-1 and the three glial transporters, GLAST-1, GLT-1 and EAAT-4, in the regulation of the synaptic glutamate platform situated below the water surface of a pool. The time they need to reach the platform decreases over a concentration is unknown and can hardly be deciphered by neurophysiological analyses because of the extensive number of trials, and this decrease is a measure for their learning ability and spatial orientation. The differences overlapping of expression in different regions of the CNS, e.g. cerebellum, hippocampus, dentate gyrus, cortical cell observed did not reach statistical significance. The eaac-1 -/-.1 mice performed better and the eaac-1 -/-.2 line layers and retina.
Here we report the first example of an in vivo analysis slightly worse than the respective control. In summary, of the function of an individual glutamate transporter, Application of NMDA to the same areas enhanced locomotion only at high concentrations (Burns et al., 1994) . EAAC-1, within the synaptic machinery by studying allelic variations. The targeted disruption of the eaac-1 gene, Injections of AMPA, but not NMDA, into the posterior zona incerta increased locomotion (Supko et al., 1991) . characterized here genetically and biochemically, has led to a loss of the EAAC-1 glutamate transporter system in If these compounds were co-injected with amphetamine, which increases dopamine release and subsequently locothe mouse.
motion, quisqualate and AMPA enhanced the amphetamine-induced locomotor activity, whereas NMDA eaac-1 -/-mice develop dicarboxylic aminoaciduria EAAC-1 is strongly expressed in kidney. The transporter showed the opposite effect. This suppression of locomotor activity by NMDA was obtained with concentrations is responsible for the tubular reabsorption of glutamate and aspartate from the glomerular filtrate. EAAC-1 deficiency one order of magnitude lower than that required for a locomotion-stimulating response in co-injection experileads to excessive glutamate and aspartate excretion by the kidney. The eaac-1 locus has been mapped to chromosome ments with quisqualate or AMPA and amphetamine (Burns et al., 1994) . 9p24 (Smith et al., 1994) . Mutations in the human EAAC-1 gene have been proposed as a cause for dicarboxylic In summary, these observations not only indicate that the neurotransmitter glutamate modulates locomotion by aminoaciduria, an inborn error of glutamate/aspartate transport across epithelial cells of kidney and intestine acting at structures of the ventral striatum, but also that different glutamate receptors mediate different effects on that was associated with mental retardation in some cases (Teijema et al., 1974; Swarna et al., 1989) , but with no locomotor activity. The precise site of administration, as well as the concentrations of glutamate agonists, seem to neurological abnormalities in another one (Melançon et al., 1977) . Our mouse model, which carries a selective defect influence the response obtained. Excitatory synapses of the eaac-1 -/-mouse are expected to have increased synaptic of EAAC-1, shows no neurological or cognitive abnormalities. Therefore, we conclude that the reported dicarboxylic glutamate concentrations due to the deficiency of the neuronal uptake system. Three interpretations of the~50% aminoaciduria associated with mental retardation and athyreosis (Teijema et al., 1974) probably represents a reduction in horizontal locomotor activity can be deduced from the experiments described above. First, among the more complex hereditary or multifactorial defect.
glutamate agonists, only the administration of NMDA suppressed locomotion, whereas agonists at AMPA or Reduced spontaneous locomotion in eaac-1 -/-mice supports evidence for a role of glutamate in quisqualate receptors always showed the opposite effect. Therefore, EAAC-1 may play a more important role at the regulation of motoric activity Three classes of glutamate receptors have been identified synapses harboring NMDA receptors than those with AMPA or quisqualate receptors. Secondly, considerably based upon their preference for one of three agonists: N-methyl-D-aspartate (NMDA), (S)-a-amino-3-hydroxy-5-higher concentrations of AMPA and quisqualate agonists than of NMDA are required to produce specific changes methylisoxazole-4-propionic acid (AMPA) or quisqualate (Curtis and Watkins, 1960; Curtis and Johnston, 1974;  in locomotor activity. The lack of EAAC-1 function may therefore lead to only very moderately increased glutamate Watkins and Evans, 1981; McLennan, 1983) .The effects of glutamate and its agonists on the locomotor activity in concentrations which elicit an NMDA response inhibiting locomotion without activating AMPA and quisqualate rodents has been studied widely. Systemic administration of low doses of NMDA reduced motor activity, whereas receptors. Such an inhibitory response via glutamate receptors might be triggered either by depolarization higher systemically administered doses led to an initial motor depression followed by an increased motor activity blockade or feed-forward inhibition mediated by GABAergic neurons (Pennartz and Kitai, 1991; Burns (Von Lubitz et al., 1993; Giménez-Llort et al., 1995) .
Intracerebral administration of quisqualate and AMPA et al., 1994) . As a third less likely possibility, the lack of an EAAC-1 reuptake system in the presynaptic membrane to the nucleus caudatus and accumbens increased the locomotor activity (Shreve and Uretsky, 1988 ; Imperato and, therefore, impaired recycling of the transmitter, may lead to a depletion of the presynaptic glutamate stores. et al Layer et al., 1991; Burns et al., 1994) .
The cytosolic glutamate pool which is sustained by transproposed to cause neurodegenerative disorders such as amyotrophic lateral sclerosis (Rothstein et al., 1992) . A amination of α-ketoglutarate and deamination of glutamine is, however, much larger than the vesicular store. It is the clinical trial showed a retarded progression of the disease by the glutamate antagonist riluzole, in patients with most likely source of the neurotransmitter in the glutamate vesicles which is predominantly replenished from the amyotrophic lateral sclerosis (Bensimon et al., 1994) . Further, glutamate-mediated neurotoxicity has been procytosolic pool rather than from recycling.
posed as a possible cause of special forms of Huntington's disease (Olney and De Gubareff, 1978 ; Perry and Hansen, EAAC-1-deficient mice develop neither neurodegeneration nor epilepsy 1990) and Alzheimer's disease (Choi, 1988; Plaitakis et al., 1988; Pomara et al., 1992) . Also, cerebral ischemia is Previous studies on the regional expression of eaac-1 in CNS (Kanai and Hediger, 1992; Rothstein et al., 1994) associated with high extracellular glutamate concentrations leading to neuron death (Choi and Rothman, 1990 ; have demonstrated its expression in striatum, hippocampus, the granular and molecular layer, and Purkinje cells of Nicholls and Attwell, 1990) . One mechanism responsible for the high extracellular glutamate concentration induced cerebellum and throughout the cortex. Defective glutamate clearance by the transporters might lead to neurotoxic by ischemia might be a presynaptic Ca 2ϩ -induced glutamate release under hypoxic conditions. Another more likely glutamate concentrations with excessive activation of postsynaptic glutamate receptors and neuron damage in mechanism might be the reversal of the electrogenic transporter system, as demonstrated in glial cells of these regions. A glutamate transporter defect has been salamander retina (Sarantis and Attwell, 1990; Szatkowski et al., 1990) . In tissue culture, astrocytes contribute much more than neurons to hypoxia-induced glutamate release (Ogata et al., 1992) . This emphasizes the importance of the glial transporter system compared with the glutamate release from presynaptic neurons. Impaired glutamate transport may play a role in all of these conditions. Our work, however, shows that the lack of EAAC-1 alone is not sufficient to produce any histological or neurological changes associated with neurodegeneration.
Several lines of evidence point towards glutamatergic transmission as a pathogenic factor in epilepsy (for a review, see Meldrum, 1994) . Local infusions of glutamate can cause seizures (Biscoe and Straughan, 1966) , while glutamate receptor antagonists have anticonvulsant properties (Croucher et al., 1982) . Autoantibodies to glutamate receptor GluR3 have been shown to be the cause of Rasmussen's encephalitis, a progressive disease of childhood which is characterized by severe epilepsy and inflammation of the brain (Rogers et al., 1994) . These Fig. 6 . Neurobehavioral assessment of eaac-1 -/-mice discloses reduced locomotor activity, but no neurological or cognitive impairment. The groups of mice tested were eaac1 null allelic mutants derived from C57BL/6 (eaac-1 -/-.1) or CD1 (eaac-1 -/-.2), as well as their respective wild-type strains C57BL/6 and CD1. For the sake of clarity, standard deviations are drawn in only one direction in (A) and (C). (A) eaac-1 -/-mice show normal motoric coordination in the Rotarod test. The median time (s) that animals were able to stay on a rod rotating at increasing speed is shown for 3 test days. On each test day, three trials were carried out on each animal. Only small statistically insignificant differences were seen, as assessed by Student's t-test (P ϭ 0.08-0.4). They were much smaller than differences between wild-type strains. (B) Spontaneous activity is markedly reduced in the open field test. The number of squares 10ϫ10 cm that the animals crossed spontaneously in an open field box 60ϫ60 cm during 5 min are drawn for three test sessions on consecutive days. eaac-1 -/-mice of both null allelic lines showed a marked reduction in locomotion compared with wild-type control mice. The difference was statistically highly significant with P Ͻ 0.01 for all values. (C) Spatial orientation in the Morris water maze is unimpaired. The median time (s) that the animals needed to find a platform, situated below the water surface of a pool 70 cm in diameter, is depicted for 20 trials. Four trials per session were carried out on 5 consecutive days. The better performance of the eaac-1 -/-.1 line and the worse performance of the eaac-1 -/-.2 line compared with control mice indicates that none of the statistically insignificant differences can be attributed to the loss of EAAC-1.
to epilepsy of the eaac-1 -/-mutants with the GABA antagonist PTZ. The susceptibility of the eaac-1 -/-mouse after a single application of PTZ did not differ from that of age-matched wild-type mice.
A recent report describes an antisense oligonucleotide 'knock out' approach of neuronal eaac-1 and of glial glast-1 and glt-1 expression (Rothstein et al., 1996) . Chronic intraventricular administration of the respective antisense oligonucleotides in vivo and to brain slices in culture led to a partial loss of functional glutamate transport activity of 35% for GLAST-1, 56% for GLT-1 and 22% for EAAC-1 antisense oligonucleotides. Mice with partial loss of functional EAAC-1 glutamate transport have been described to develop a motor syndrome with slow hind limb movement, atactic gait, hind limb paresis and, most notably, these mice produced epilepsy with clonic seizures. These findings are contradictory to the phenotype of the eaac-1 -/-mouse described here.
We also investigated a possible apoptosis of neurons due to increased synaptic glutamate concentration using the in situ immunoperoxidase detection of digoxigeninlabeled genomic DNA of apoptotic cells (TUNEL assay) in cryosections. We were not able to detect any difference between wild-type and mutant mice. The same negative result to demonstrate astro-glial reactivity was obtained when anti-GAFP antibodies were applied to cryothin sections of wild-type and eaac-1 -/-mice.
In summary, the EAAC-1-deficient mouse gives first insight into the relative role in vivo of the neuronal glutamate transporter. The expected neuropathological phenotype due to the EAAC-1 deficiency and a presumed elevation of synaptic glutamate concentration to toxic levels is missing in the hetero-and homozygous mutant. a function other than the stringent regulation of the synaptic glutamate concentration and, therefore, not be intimately related to the plasticity of glutamatergic autoantibodies not only bind, but also activate GluR3, thereby leading to exaggerated excitatory neurotransmissynapses.
Our quantitative Northern blot analysis and radiosion and seizures (Twyman et al., 1995) . The excitatory neurotransmission mediated by glutamate seems to be labeling RT-PCR make the first hypothesis very unlikely, as no enhanced expression of either GLAST-1 or GLT-1 controlled by the inhibitory effects of GABA. The rise of extracellular glutamate concentrations during epileptic was observed in the eaac-1 -/-mouse within the limit of accuracy of these methods. In view of the low abundance seizures leads to a subsequent GABA release from neurons and the surrounding glial cells (During et al., 1995) . The of EAAC-1 mRNA and protein in the mouse brain, we question a vital function of EAAC-1 in the regulation of balance between glutamate and GABA release seems to be disturbed in epileptogenic human hippocampi (During synaptic L-glutamate concentrations, unless other as yet unknown glutamate transporters compensate for the loss and Spencer, 1993).
The lack of EAAC-1 function was expected to lead to an of EAAC-1 function in the null-allelic eaac-1 -/-mouse. Therefore, the glial transporters may play the pivotal increased synaptic glutamate concentration, an imbalance between glutamate and GABA, and an increased susceptirole in the neurotransmitter uptake system and also in preventing short-and long-term neurotoxicity. bility to epileptic seizures. However, no spontaneous epileptic seizures have been observed in eaac-1 -/-mice Most current strategies that aim at the protection of neurons from post-ischemic and other glutamate overflow during a period of Ͼ9 months.
We therefore challenged a possible latent susceptibility conditions and its neurotoxicity address the regulation of They were washed in 2ϫ SSC, 1% SDS at 55-65°C. Radioactive signals the presynaptic glutamate release and the postsynaptic on the membranes were detected using a PhosphorImager (Molecular receptor systems. The glutamate transporter system might Dynamics). GAPDH mRNA signals were used as internal standard to be a third target for manipulating the excitatory synapse.
ensure the application of equal amounts of RNA. 
Generation of antibodies and Western blot analysis

Materials and methods
The peptide QYKTKREEVKPVGDP, corresponding to amino acid residues 161-175 of murine EAAC-1 (Mukainaka et al., 1995) , was Isolation of the mouse EAAC-1 gene coupled to KLH (Goodfriend et al., 1964) . A total of 200 μg of peptide/ A λgt10 rat brain cDNA library (Storck et al., 1992) was screened with KLH in 250 μl PBS were homogenized with 250 μl complete Freund's a 642 bp PCR fragment that had been obtained using the 5Ј pool primer adjuvant and a New Zealand white rabbit was immunized by i.m. AATCTGGTAGAAGCCTGCTTTAAACAG and the 3Ј pool primer injection. Booster injections were carried out in the same way with ACCATAACATGGATGGGACCGCCC. A full-length 2048 bp rat incomplete Freund's adjuvant at biweekly intervals. The rise of the EAAC-1 cDNA clone was isolated. After radiolabeling, this rat EAAC-1 antibody titer was monitored by ELISA (Engvall, 1980) using peptide cDNA was used to screen a Balb/c mouse genomic library (Clontech coupled to bovine serum albumin (Reichlin, 1980) . Serum was affinity ML1040j) (Sambrook et al., 1989) . Three overlapping genomic clones purified on a Sepharose column with the above-mentioned peptide were isolated and the eaac-1 organization was established by restriction covalently linked. mapping. Eight of the exons were sequenced.
Mice were killed by cranial dislocation and organs were removed, The EAAC-1 targeting vector pEAAC-1KO contained a 7 kb XbaI homogenized in 0.25 M sucrose and centrifuged at 800 g for 5 min to restriction fragment of clone M3 with exon 1 flanked by 4 kb of genomic remove nuclei. Plasma membranes were then sedimented by centrifuga-DNA on the 5Ј side and 3 kb on the 3Ј side. It was inserted into the tion at 2500 g for 10 min, and the pellet was washed once in PBS and XbaI restriction site of pBluescript SKIIϩ. Exon 1 was disrupted by dissolved in electrophoresis sample buffer containing 10% SDS. Western insertion of a pgk neomycin resistance gene cassette (neo) into an NarI blot analysis was performed according to standard procedures (Sambrook restriction site in sense orientation. A thymidine kinase expression box et al., 1989) . was inserted into the unique NotI site of the pBluescript SKIIϩ 5Ј of An anti-GLT-1 peptide antibody was also kindly supplied by the genomic fragment.
Dr B.Kanner, Hadassah Medical School, Jerusalem.
Generation and identification of ES cell clones and Comparative RT-PCR analysis null-allelic mice
For comparative RT-PCR analysis of brain RNA of wild-type and eaacMouse ES cells (R1 genotype, kindly provided by Dr A.Nagy, University 1 -/-mice for GLAST-1 and GLT-1 expression, the following RNA sense of Toronto) were grown to 90% confluency on feeder layers of mitomycin (s) and antisense (as) primers were used. C-treated G418-resistant mouse embryonic fibroblasts (Robertson, 1987) .
GLAST - The reactions were carried out according to standard protocols electrophoresis in 0.5% agarose, followed by Southern blotting using a (Kawasaki, 1990) . randomly 32 P-labeled 1.6 kb SalI/SstI probe from the region flanking Tubes contained equal aliquots of RNA for RT reactions added at the 5Ј end of the genomic fragment. After hybridization, blots were several dilutions. The PCR program included an initial denaturation at washed and exposed to Kodak AR5 X-ray film for 48 h or scanned with 94°C for 5 min, followed by 35 cycles with the following steps: a PhosphorImager (Molecular Dynamics). The expected size for mutant denaturation at 94°C for 30 s, annealing at 60°C for 30 s, elongation at eaac-1 (9 kb) was 2 kb less than that for wild type (11 kb) due to an 72°C for 2 min. Using the Image Quant software program, relative EcoRI restriction site inserted with the neo box.
intensities of the PCR fragments within the series were correlated with Blastocysts of C57BL/6 and CD1 females were injected with 10-25 the fragment of the wild-type and the eaac-1 -/-mouse. cells of targeted clones, and groups of 5-14 blastocysts were transferred into pseudopregnant CD1 females as described (Bradley et al., 1984; Hogan et al., 1986) . Chimeric male offspring were mated to C57BL/6
In situ apoptosis detection or CD1 females, according to the origin of the blastocysts. We monitored Cryosections (7 μm) of paraformaldehyde-perfused wild-type and eaacgermline transmission of the injected ES cells by the inheritance of agouti 1 -/-mouse brains were subjected to the in situ apoptosis assay by coat color. Heterozygous and homozygous offspring were identified by direct immunoperoxidase detection of digoxigenin-labeled genomic DNA Southern blotting, as described for ES cells, as well as PCR analysis of (TUNEL assay). The ApopTag in situ apoptosis detection kit (Oncor, tail DNA. The positions of the two oligonucleotide primers were chosen Gaithersburg, MD) was used following the manufacturer's instructions. to yield a 250 bp PCR fragment with the wild type and a 1.2 kb fragment with exon 1 disrupted by the neo cassette, for the mutant template.
In situ hybridization Mice were killed and organs removed as described below under Histology. After post-fixation, organs were incubated three times for 5 min in PBS RNA analysis Northern blot analysis was carried out according to standard procedures and dehydrated overnight in 0.5 M sucrose/PBS. They were embedded in an embedding medium for cryosections (OCT Compound 4583, (Sambrook et al., 1989) . Total RNA of 25-to 30-day-old mice was extracted from brain, kidney, small intestine and lung as described Tissue-Tek), and 7 μm cryosections were cut. For detection of EAAC-1 mRNA, the 642 bp mouse EAAC-1-specific (Chomczynski and Sacchi, 1987) . Forty micrograms of RNA were separated on 1% agarose/formaldehyde gels and blotted onto nylon PCR fragment (see the previous section: isolation of the mouse EAAC-1 gene) was labeled with digoxigenin-coupled UTP using the DIG RNA membranes by capillary transfer using 20ϫ SSC. Membranes were dried for 15 min at 80°C, wetted in 2ϫ SSC and hybridized overnight at 42°C
Labeling Kit (SP6/T7) (Boehringer Mannheim) according to the manufacturer's instructions and hybridized to EAAC-1 mRNA in brain sections. in 25% formamide, 1 M NaCl, 1% SDS, 5% dextran sulfate with a 32 Plabeled 1.0 kb NarI probe (base 32-1079) from rat EAAC-1 cDNA.
Bound probe was visualized with anti-digoxigenin antibodies and alkaline phosphatase-coupled second antibodies using the DIG Nucleic Acid of brain glutamate transporters by protein kinase C. 
